Clinical trial
A Single-Center, Evaluator-blind, Randomized Control Study to Assess the Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration
NCT06252935 is registered in ClinicalTrials.gov with Maxigen Biotech Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Evaluator-blind, Randomized Control Study to Assess the Effectiveness and Safety of Collagen Membrane (FormaAid®) in the Treatment of Periodontal Regeneration
- Lead sponsor
- Maxigen Biotech Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 30, 2024
- Completion date
- October 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
collagen membrane, dental diseases, guided tissue regeneration